Baxter is firmly committed to support patients and their healthcare providers throughout the entire continuum of care - from acute kidney injury to end-stage chronic kidney disease.
Introducing the next evolution in hemodialysis that brings us a step closer to the natural kidney through superior removal of an expanded range of conventional/large middle molecules (up to 45,000 Da),
Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.
PD, combined with Remote Patient Management, offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.
Baxter’s product portfolio for acute and chronic kidney failure offers a comprehensive approach to renal care.
Entire Product PortfolioDevices
Filters & Disposables
Solutions
Explore our full library of educational content and product resources.
We have consolidated support resources to help you with provide critically ill patients Continuous Renal Replacement Therapy.
Doctors, nurses and pharmacists discuss their experiences with the Baxter CRRT program.